Report cover image

Global Radiolabeled Compounds Synthesis Service Market Analysis and Forecast 2026-2032

Publisher APO Research, Inc.
Published Dec 28, 2025
Length 198 Pages
SKU # APRC20795304

Description

The global Radiolabeled Compounds Synthesis Service market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Radiolabeled Compounds Synthesis Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Radiolabeled Compounds Synthesis Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Asia-Pacific market for Radiolabeled Compounds Synthesis Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Radiolabeled Compounds Synthesis Service is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Radiolabeled Compounds Synthesis Service include Eurofins, Revvity, Selcia, Labcorp, Pharmaron, WuXi AppTec, AM Chemicals, SEKISUI MEDICAL CO., LTD. and Nuvisan, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Radiolabeled Compounds Synthesis Service, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Radiolabeled Compounds Synthesis Service, also provides the revenue of main regions and countries. Of the upcoming market potential for Radiolabeled Compounds Synthesis Service, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Radiolabeled Compounds Synthesis Service revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Radiolabeled Compounds Synthesis Service market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Radiolabeled Compounds Synthesis Service revenue, projected growth trends, production technology, application and end-user industry.

Radiolabeled Compounds Synthesis Service Segment by Company

Eurofins
Revvity
Selcia
Labcorp
Pharmaron
WuXi AppTec
AM Chemicals
SEKISUI MEDICAL CO., LTD.
Nuvisan
Almac
Novandi Chemistry
Alfa Cytology
Institute of Isotopes Co. Ltd.
Headway
ViTrax

Radiolabeled Compounds Synthesis Service Segment by Type

Carbon-14 Radiosynthesis Services
Hydrogen-3 Radiosynthesis Services
Chiral Separation and Salt Formation
Others

Radiolabeled Compounds Synthesis Service Segment by Application

Medical Diagnosis and Treatment
Material Science
Nuclear Energy
Others

Radiolabeled Compounds Synthesis Service Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Radiolabeled Compounds Synthesis Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Radiolabeled Compounds Synthesis Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Radiolabeled Compounds Synthesis Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Radiolabeled Compounds Synthesis Service in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Radiolabeled Compounds Synthesis Service company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Radiolabeled Compounds Synthesis Service revenue, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.

Table of Contents

198 Pages
1 Market Overview
1.1 Product Definition
1.2 Radiolabeled Compounds Synthesis Service Market by Type
1.2.1 Global Radiolabeled Compounds Synthesis Service Market Size by Type, 2021 VS 2025 VS 2032
1.2.2 Carbon-14 Radiosynthesis Services
1.2.3 Hydrogen-3 Radiosynthesis Services
1.2.4 Chiral Separation and Salt Formation
1.2.5 Others
1.3 Radiolabeled Compounds Synthesis Service Market by Application
1.3.1 Global Radiolabeled Compounds Synthesis Service Market Size by Application, 2021 VS 2025 VS 2032
1.3.2 Medical Diagnosis and Treatment
1.3.3 Material Science
1.3.4 Nuclear Energy
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Radiolabeled Compounds Synthesis Service Market Dynamics
2.1 Radiolabeled Compounds Synthesis Service Industry Trends
2.2 Radiolabeled Compounds Synthesis Service Industry Drivers
2.3 Radiolabeled Compounds Synthesis Service Industry Opportunities and Challenges
2.4 Radiolabeled Compounds Synthesis Service Industry Restraints
3 Global Growth Perspective
3.1 Global Radiolabeled Compounds Synthesis Service Market Perspective (2021-2032)
3.2 Global Radiolabeled Compounds Synthesis Service Growth Trends by Region
3.2.1 Global Radiolabeled Compounds Synthesis Service Market Size by Region: 2021 VS 2025 VS 2032
3.2.2 Global Radiolabeled Compounds Synthesis Service Market Size by Region (2021-2026)
3.2.3 Global Radiolabeled Compounds Synthesis Service Market Size by Region (2027-2032)
4 Competitive Landscape by Players
4.1 Global Radiolabeled Compounds Synthesis Service Revenue by Players
4.1.1 Global Radiolabeled Compounds Synthesis Service Revenue by Players (2021-2026)
4.1.2 Global Radiolabeled Compounds Synthesis Service Revenue Market Share by Players (2021-2026)
4.1.3 Global Radiolabeled Compounds Synthesis Service Players Revenue Share Top 10 and Top 5 in 2025
4.2 Global Radiolabeled Compounds Synthesis Service Key Players Ranking, 2024 VS 2025 VS 2026
4.3 Global Radiolabeled Compounds Synthesis Service Key Players Headquarters & Area Served
4.4 Global Radiolabeled Compounds Synthesis Service Players, Product Type & Application
4.5 Global Radiolabeled Compounds Synthesis Service Players Establishment Date
4.6 Market Competitive Analysis
4.6.1 Global Radiolabeled Compounds Synthesis Service Market CR5 and HHI
4.6.3 2025 Radiolabeled Compounds Synthesis Service Tier 1, Tier 2, and Tier 3
5 Radiolabeled Compounds Synthesis Service Market Size by Type
5.1 Global Radiolabeled Compounds Synthesis Service Revenue by Type (2021 VS 2025 VS 2032)
5.2 Global Radiolabeled Compounds Synthesis Service Revenue by Type (2021-2032)
5.3 Global Radiolabeled Compounds Synthesis Service Revenue Market Share by Type (2021-2032)
6 Radiolabeled Compounds Synthesis Service Market Size by Application
6.1 Global Radiolabeled Compounds Synthesis Service Revenue by Application (2021 VS 2025 VS 2032)
6.2 Global Radiolabeled Compounds Synthesis Service Revenue by Application (2021-2032)
6.3 Global Radiolabeled Compounds Synthesis Service Revenue Market Share by Application (2021-2032)
7 Company Profiles
7.1 Eurofins
7.1.1 Eurofins Company Information
7.1.2 Eurofins Business Overview
7.1.3 Eurofins Radiolabeled Compounds Synthesis Service Revenue and Gross Margin (2021-2026)
7.1.4 Eurofins Radiolabeled Compounds Synthesis Service Product Portfolio
7.1.5 Eurofins Recent Developments
7.2 Revvity
7.2.1 Revvity Company Information
7.2.2 Revvity Business Overview
7.2.3 Revvity Radiolabeled Compounds Synthesis Service Revenue and Gross Margin (2021-2026)
7.2.4 Revvity Radiolabeled Compounds Synthesis Service Product Portfolio
7.2.5 Revvity Recent Developments
7.3 Selcia
7.3.1 Selcia Company Information
7.3.2 Selcia Business Overview
7.3.3 Selcia Radiolabeled Compounds Synthesis Service Revenue and Gross Margin (2021-2026)
7.3.4 Selcia Radiolabeled Compounds Synthesis Service Product Portfolio
7.3.5 Selcia Recent Developments
7.4 Labcorp
7.4.1 Labcorp Company Information
7.4.2 Labcorp Business Overview
7.4.3 Labcorp Radiolabeled Compounds Synthesis Service Revenue and Gross Margin (2021-2026)
7.4.4 Labcorp Radiolabeled Compounds Synthesis Service Product Portfolio
7.4.5 Labcorp Recent Developments
7.5 Pharmaron
7.5.1 Pharmaron Company Information
7.5.2 Pharmaron Business Overview
7.5.3 Pharmaron Radiolabeled Compounds Synthesis Service Revenue and Gross Margin (2021-2026)
7.5.4 Pharmaron Radiolabeled Compounds Synthesis Service Product Portfolio
7.5.5 Pharmaron Recent Developments
7.6 WuXi AppTec
7.6.1 WuXi AppTec Company Information
7.6.2 WuXi AppTec Business Overview
7.6.3 WuXi AppTec Radiolabeled Compounds Synthesis Service Revenue and Gross Margin (2021-2026)
7.6.4 WuXi AppTec Radiolabeled Compounds Synthesis Service Product Portfolio
7.6.5 WuXi AppTec Recent Developments
7.7 AM Chemicals
7.7.1 AM Chemicals Company Information
7.7.2 AM Chemicals Business Overview
7.7.3 AM Chemicals Radiolabeled Compounds Synthesis Service Revenue and Gross Margin (2021-2026)
7.7.4 AM Chemicals Radiolabeled Compounds Synthesis Service Product Portfolio
7.7.5 AM Chemicals Recent Developments
7.8 SEKISUI MEDICAL CO., LTD.
7.8.1 SEKISUI MEDICAL CO., LTD. Company Information
7.8.2 SEKISUI MEDICAL CO., LTD. Business Overview
7.8.3 SEKISUI MEDICAL CO., LTD. Radiolabeled Compounds Synthesis Service Revenue and Gross Margin (2021-2026)
7.8.4 SEKISUI MEDICAL CO., LTD. Radiolabeled Compounds Synthesis Service Product Portfolio
7.8.5 SEKISUI MEDICAL CO., LTD. Recent Developments
7.9 Nuvisan
7.9.1 Nuvisan Company Information
7.9.2 Nuvisan Business Overview
7.9.3 Nuvisan Radiolabeled Compounds Synthesis Service Revenue and Gross Margin (2021-2026)
7.9.4 Nuvisan Radiolabeled Compounds Synthesis Service Product Portfolio
7.9.5 Nuvisan Recent Developments
7.10 Almac
7.10.1 Almac Company Information
7.10.2 Almac Business Overview
7.10.3 Almac Radiolabeled Compounds Synthesis Service Revenue and Gross Margin (2021-2026)
7.10.4 Almac Radiolabeled Compounds Synthesis Service Product Portfolio
7.10.5 Almac Recent Developments
7.11 Novandi Chemistry
7.11.1 Novandi Chemistry Company Information
7.11.2 Novandi Chemistry Business Overview
7.11.3 Novandi Chemistry Radiolabeled Compounds Synthesis Service Revenue and Gross Margin (2021-2026)
7.11.4 Novandi Chemistry Radiolabeled Compounds Synthesis Service Product Portfolio
7.11.5 Novandi Chemistry Recent Developments
7.12 Alfa Cytology
7.12.1 Alfa Cytology Company Information
7.12.2 Alfa Cytology Business Overview
7.12.3 Alfa Cytology Radiolabeled Compounds Synthesis Service Revenue and Gross Margin (2021-2026)
7.12.4 Alfa Cytology Radiolabeled Compounds Synthesis Service Product Portfolio
7.12.5 Alfa Cytology Recent Developments
7.13 Institute of Isotopes Co. Ltd.
7.13.1 Institute of Isotopes Co. Ltd. Company Information
7.13.2 Institute of Isotopes Co. Ltd. Business Overview
7.13.3 Institute of Isotopes Co. Ltd. Radiolabeled Compounds Synthesis Service Revenue and Gross Margin (2021-2026)
7.13.4 Institute of Isotopes Co. Ltd. Radiolabeled Compounds Synthesis Service Product Portfolio
7.13.5 Institute of Isotopes Co. Ltd. Recent Developments
7.14 Headway
7.14.1 Headway Company Information
7.14.2 Headway Business Overview
7.14.3 Headway Radiolabeled Compounds Synthesis Service Revenue and Gross Margin (2021-2026)
7.14.4 Headway Radiolabeled Compounds Synthesis Service Product Portfolio
7.14.5 Headway Recent Developments
7.15 ViTrax
7.15.1 ViTrax Company Information
7.15.2 ViTrax Business Overview
7.15.3 ViTrax Radiolabeled Compounds Synthesis Service Revenue and Gross Margin (2021-2026)
7.15.4 ViTrax Radiolabeled Compounds Synthesis Service Product Portfolio
7.15.5 ViTrax Recent Developments
8 North America
8.1 North America Radiolabeled Compounds Synthesis Service Revenue (2021-2032)
8.2 North America Radiolabeled Compounds Synthesis Service Revenue by Type (2021-2032)
8.2.1 North America Radiolabeled Compounds Synthesis Service Revenue by Type (2021-2026)
8.2.2 North America Radiolabeled Compounds Synthesis Service Revenue by Type (2027-2032)
8.3 North America Radiolabeled Compounds Synthesis Service Revenue Share by Type (2021-2032)
8.4 North America Radiolabeled Compounds Synthesis Service Revenue by Application (2021-2032)
8.4.1 North America Radiolabeled Compounds Synthesis Service Revenue by Application (2021-2026)
8.4.2 North America Radiolabeled Compounds Synthesis Service Revenue by Application (2027-2032)
8.5 North America Radiolabeled Compounds Synthesis Service Revenue Share by Application (2021-2032)
8.6 North America Radiolabeled Compounds Synthesis Service Revenue by Country
8.6.1 North America Radiolabeled Compounds Synthesis Service Revenue by Country (2021 VS 2025 VS 2032)
8.6.2 North America Radiolabeled Compounds Synthesis Service Revenue by Country (2021-2026)
8.6.3 North America Radiolabeled Compounds Synthesis Service Revenue by Country (2027-2032)
8.6.4 United States
8.6.5 Canada
8.6.6 Mexico
9 Europe
9.1 Europe Radiolabeled Compounds Synthesis Service Revenue (2021-2032)
9.2 Europe Radiolabeled Compounds Synthesis Service Revenue by Type (2021-2032)
9.2.1 Europe Radiolabeled Compounds Synthesis Service Revenue by Type (2021-2026)
9.2.2 Europe Radiolabeled Compounds Synthesis Service Revenue by Type (2027-2032)
9.3 Europe Radiolabeled Compounds Synthesis Service Revenue Share by Type (2021-2032)
9.4 Europe Radiolabeled Compounds Synthesis Service Revenue by Application (2021-2032)
9.4.1 Europe Radiolabeled Compounds Synthesis Service Revenue by Application (2021-2026)
9.4.2 Europe Radiolabeled Compounds Synthesis Service Revenue by Application (2027-2032)
9.5 Europe Radiolabeled Compounds Synthesis Service Revenue Share by Application (2021-2032)
9.6 Europe Radiolabeled Compounds Synthesis Service Revenue by Country
9.6.1 Europe Radiolabeled Compounds Synthesis Service Revenue by Country (2021 VS 2025 VS 2032)
9.6.2 Europe Radiolabeled Compounds Synthesis Service Revenue by Country (2021-2026)
9.6.3 Europe Radiolabeled Compounds Synthesis Service Revenue by Country (2027-2032)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
9.6.9 Spain
9.6.10 Netherlands
9.6.11 Switzerland
9.6.12 Sweden
9.6.13 Poland
10 China
10.1 China Radiolabeled Compounds Synthesis Service Revenue (2021-2032)
10.2 China Radiolabeled Compounds Synthesis Service Revenue by Type (2021-2032)
10.2.1 China Radiolabeled Compounds Synthesis Service Revenue by Type (2021-2026)
10.2.2 China Radiolabeled Compounds Synthesis Service Revenue by Type (2027-2032)
10.3 China Radiolabeled Compounds Synthesis Service Revenue Share by Type (2021-2032)
10.4 China Radiolabeled Compounds Synthesis Service Revenue by Application (2021-2032)
10.4.1 China Radiolabeled Compounds Synthesis Service Revenue by Application (2021-2026)
10.4.2 China Radiolabeled Compounds Synthesis Service Revenue by Application (2027-2032)
10.5 China Radiolabeled Compounds Synthesis Service Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
11.1 Asia Radiolabeled Compounds Synthesis Service Revenue (2021-2032)
11.2 Asia Radiolabeled Compounds Synthesis Service Revenue by Type (2021-2032)
11.2.1 Asia Radiolabeled Compounds Synthesis Service Revenue by Type (2021-2026)
11.2.2 Asia Radiolabeled Compounds Synthesis Service Revenue by Type (2027-2032)
11.3 Asia Radiolabeled Compounds Synthesis Service Revenue Share by Type (2021-2032)
11.4 Asia Radiolabeled Compounds Synthesis Service Revenue by Application (2021-2032)
11.4.1 Asia Radiolabeled Compounds Synthesis Service Revenue by Application (2021-2026)
11.4.2 Asia Radiolabeled Compounds Synthesis Service Revenue by Application (2027-2032)
11.5 Asia Radiolabeled Compounds Synthesis Service Revenue Share by Application (2021-2032)
11.6 Asia Radiolabeled Compounds Synthesis Service Revenue by Country
11.6.1 Asia Radiolabeled Compounds Synthesis Service Revenue by Country (2021 VS 2025 VS 2032)
11.6.2 Asia Radiolabeled Compounds Synthesis Service Revenue by Country (2021-2026)
11.6.3 Asia Radiolabeled Compounds Synthesis Service Revenue by Country (2027-2032)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 Taiwan
11.6.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Radiolabeled Compounds Synthesis Service Revenue (2021-2032)
12.2 SAMEA Radiolabeled Compounds Synthesis Service Revenue by Type (2021-2032)
12.2.1 SAMEA Radiolabeled Compounds Synthesis Service Revenue by Type (2021-2026)
12.2.2 SAMEA Radiolabeled Compounds Synthesis Service Revenue by Type (2027-2032)
12.3 SAMEA Radiolabeled Compounds Synthesis Service Revenue Share by Type (2021-2032)
12.4 SAMEA Radiolabeled Compounds Synthesis Service Revenue by Application (2021-2032)
12.4.1 SAMEA Radiolabeled Compounds Synthesis Service Revenue by Application (2021-2026)
12.4.2 SAMEA Radiolabeled Compounds Synthesis Service Revenue by Application (2027-2032)
12.5 SAMEA Radiolabeled Compounds Synthesis Service Revenue Share by Application (2021-2032)
12.6 SAMEA Radiolabeled Compounds Synthesis Service Revenue by Country
12.6.1 SAMEA Radiolabeled Compounds Synthesis Service Revenue by Country (2021 VS 2025 VS 2032)
12.6.2 SAMEA Radiolabeled Compounds Synthesis Service Revenue by Country (2021-2026)
12.6.3 SAMEA Radiolabeled Compounds Synthesis Service Revenue by Country (2027-2032)
12.6.4 Brazil
12.6.5 Argentina
12.6.6 Chile
12.6.7 Colombia
12.6.8 Peru
12.6.9 Saudi Arabia
12.6.10 Israel
12.6.11 UAE
12.6.12 Turkey
12.6.13 Iran
12.6.14 Egypt
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.